基于“体质可调”浅析肥胖型多囊卵巢综合征的防治

摘要: 多囊卵巢综合征(polycystic ovarian syndrome，PCOS)是一种异质性疾病，与女性内分泌生殖障碍有关，是导致育龄妇女继发闭经、月经周期不规律、无排卵性不孕的主要原因，临床表现为月经稀发、月经量少、多毛症和痤疮、肥胖、不孕等。近年来随着社会经济的发展、自然环境的变化，PCOS合并肥胖人数逐渐增加，处于育龄期的妇女所面临的心理和生理压力也与日俱增，这些压力对其身心健康及生活质量都造成了严重的影响。肥胖不仅会对PCOS患者造成生理上的影响，同时也会增加患者的心理负担，从而使患者产生抑郁、焦虑、烦躁、自卑等负性情绪。研究指出，肥胖型PCOS患者不仅面临体重增加、难以减轻的问题，还更容易出现焦虑、烦躁和抑郁等情绪问题。与未患PCOS的女性相比，PCOS女性的心理问题更突出，自尊感较低，身体意象更负面。肥胖型PCOS患者的内分泌代谢紊乱情况较常人更为严重。同时，患者不孕症疗效不佳的概率会提高，并且可能增加怀孕妇女妊娠并发症的发生风险。本文参考近几年的文献资料，基于中医“体质可调”理论，探讨肥胖型PCOS的预防策略，以期为预防和治疗肥胖型PCOS及其并发症提供新的思路。
- 体质 /
- 肥胖 /
- 多囊卵巢综合征
Abstract: Polycystic ovarian syndrome (PCOS) is a heterogeneous disease related to female endocrine and reproductive disorders, and it is the main cause of secondary amenorrhea, irregular menstrual cycles, and anovulatory infertility in women of childbearing age. Clinical manifestations include oligomenorrhea, hirsutism, acne, obesity, and infertility. In recent years, with the development of the social economy and the change of natural environment, the number of obese patients with PCOS gradually increased, and the psychological and physiological pressure faced by women of childbearing age also increased. These pressures have seriously impacted their physical and mental health and quality of life. Obesity not only has physiological effects on patients with PCOS, but also increases their psychological burden, causing negative emotions such as depression, anxiety, irritability, low self-esteem, and depression. Studies have shown that obese patients with PCOS not only faced the problems of weight gain and weight loss, but also more likely to have emotional problems such as anxiety, irritability, and depression. Compared with women without PCOS, women with PCOS have more serious psychological problems, weaker self-esteem, and more negative body image. Endocrine and metabolic disorders of obese patients with PCOS are more serious than those of ordinary people. At the same time, the probability of poor efficacy in treating patients with infertility increases, which may increase the risk of pregnancy complications in pregnant women. This paper discusses the prevention strategies of obese patients with PCOS by consulting the resent literature and combining with the theory of "adjustable constitution" in traditional Chinese medicine. The aim is to provide new ideas for the prevention and treatment of obese patients with PCOS.
- Physical constitution /
- Obesity /
- Polycystic ovarian syndrome

HTML全文

参考文献(41)

[1]	沈文娟, 尤天娇, 金宝, 等. 多囊卵巢综合征中西医病因病机及治疗研究进展[J]. 辽宁中医杂志, 2021, 48(12): 196-199. SHEN W J, YOU T J, JIN B, et al. Research progress on the etiology, pathogenesis, and treatment of polycystic ovary syndrome in traditional Chinese and western medicine[J]. Liaoning Journal of Traditional Chinese Medicine, 2021, 48(12): 196-199.
[2]	刘恭雪, 仇华, 蔡平平. 肥胖型多囊卵巢综合征中西医研究进展[J]. 湖南中医杂志, 2021, 37(6): 184-188. LIU G X, QIU H, CAI P P. Research progress in traditional Chinese and western medicine for obese polycystic ovary syndrome[J]. Hunan Journal of Traditional Chinese Medicine, 2021, 37(6): 184-188.
[3]	覃潆玉, 刘佳瑞, 郑瑞茂. 肥胖治疗的研究进展[J]. 生理科学进展, 2020, 51(3): 167-173. QIN Y Y, LIU J R, ZHENG R M. Research progress in obesity treatment[J]. Progress in Physiological Sciences, 2020, 51(3): 167-173.
[4]	LEGRO R S. Obesity and PCOS: implications for diagnosis and treatment[J]. Semin Reprod Med, 2012, 30(6): 496-506. doi: 10.1055/s-0032-1328878
[5]	孙淼, 王玉艳, 孟小钰, 等. 基于"肾虚、痰湿、血瘀"的现代生物学基础探讨PCOS中医病机的科学内涵[J]. 时珍国医国药, 2022, 33(6): 1412-1415. doi: 10.3969/j.issn.1008-0805.2022.06.40 SUN M, WANG Y Y, MENG X Y, et al. Exploring the scientific connotation of the pathogenesis of PCOS in traditional chinese medicine based on the modern biological basis of "kidney deficiency, phlegm dampness, and blood stasis"[J]. Lishizhen Medicine and Materia Medica Research, 2022, 33(6): 1412-1415. doi: 10.3969/j.issn.1008-0805.2022.06.40
[6]	陈学奇, 葛蓓芬. 《陈素庵妇科补解》调经特色浅析[J]. 浙江中医药大学学报, 2018, 42(5): 374-376. CHEN X Q, GE B F. Analysis of the characteristics of menstrual regulation in "Chen Su ' an Gynecology Supplement"[J]. Journal of Zhejiang Chinese Medical University, 2018, 42(5): 374-376.
[7]	韩延华, 冯聪, 齐娜. 基于数据挖掘技术分析全国中医妇科名家诊治不孕症的共性用药规律[J]. 世界中医药, 2022, 17(1): 117-122. HAN Y H, FENG C, QI N. Analysis of common medication patterns in the diagnosis and treatment of infertility by renowned gynecologists of traditional Chinese medicine in China based on data mining technology[J]. World Chinese Medicine, 2022, 17(1): 117-122.
[8]	王琦. 9种基本中医体质类型的分类及其诊断表述依据[J]. 北京中医药大学学报, 2005(4): 1-8. WANG Q. Classification and diagnostic criteria for 9 basic types of traditional Chinese medicine constitution[J]. Journal of Beijing University of Traditional Chinese Medicine, 2005(4): 1-8.
[9]	周正, 郭洁, 刘培枝, 等. 基于古代文献探讨肥胖与疾病相关性[J]. 中国民族民间医药, 2018, 27(3): 26-27. ZHOU Z, GUO J, LIU P Z, et al. Exploring the correlation between obesity and diseases based on ancient literature[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2018, 27(3): 26-27.
[10]	陈锦明, 张芬, 邓姣, 等. 中医体质类型与多囊卵巢综合征相关性的meta分析[J]. 中华全科医学, 2022, 20(4): 691-695. doi: 10.16766/j.cnki.issn.1674-4152.002432 CHEN J M, ZHANG F, DENG J, et al. Meta analysis of the correlation between traditional Chinese medicine constitution types and polycystic ovary syndrome[J]. Chinese Journal of General Practice, 2022, 20(4): 691-695. doi: 10.16766/j.cnki.issn.1674-4152.002432
[11]	杨珺兰, 王泽, 邹晓燕, 等. PCOS肥胖脂代谢特点及相关基因研究进展[J]. 现代妇产科进展, 2022, 31(5): 377-379, 383. YANG J L, WANG Z, ZOU X Y, et al. Research progress on lipid metabolism characteristics and related genes in PCOS obesity[J]. Progress in Obstetrics and Gynecology, 2022, 31(5): 377-383.
[12]	中华中医药学会. 中医体质分类与判定[M]. 北京: 中国中医药出版社, 2009: 1-8. Chinese Association of Traditional Chinese Medicine. Classification and Determination of Traditional Chinese Medicine Constitution[M]. Beijing: China Press of Traditional Chinese Medicine, 2009: 1-8.
[13]	庞羽, 李楠, 贺丰杰. 从"体质可调"浅论多囊卵巢综合征的预防[J]. 现代中西医结合杂志, 2019, 28(1): 45-47, 102. PANG Y, LI N, HE F J. Prevention of polycystic ovary syndrome from the perspective of "adjustable constitution"[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2019, 28(1): 45-47.
[14]	潘紫萌, 侯丽辉, 孙淼, 等. 肥胖与代谢综合征对多囊卵巢综合征患者中医体质分布及代谢的影响[J]. 中华中医药杂志, 2022, 37(3): 1656-1661. PAN Z M, HOU L H, SUN M, et al. The impact of obesity and metabolic syndrome on the distribution and metabolism of traditional Chinese medicine constitution in patients with polycystic ovary syndrome[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2022, 37(3): 1656-1661.
[15]	李瑞丽, 傅金英, 杜蕾, 等. 多囊卵巢综合征患者中医体质分布特征调查[J]. 中医学报, 2013, 28(8): 1192-1193. LI R L, FU J Y, DU L, et al. Investigation on the distribution characteristics of traditional Chinese medicine constitution in patients with polycystic ovary syndrome[J]. Acta Chinese Medicine, 2013, 28(8): 1192-1193.
[16]	刘静君, 王东梅, 蔡平平, 等. 多囊卵巢综合征的体质类型及其与BMI相关性的流行病学研究[J]. 山东中医杂志, 2017, 36(2): 106-109. LIU J J, WANG D M, CAI P P, et al. Epidemiological study on constitution types and their correlation with BMI in polycystic ovary syndrome[J]. Shandong Journal of Traditional Chinese Medicine, 2017, 36(2): 106-109.
[17]	符丽荣, 丁竹筠. 肥胖型多囊卵巢综合征患者的内分泌特征及治疗分析[J]. 智慧健康, 2019, 5(7): 44-46. FU L R, DING Z Y. Endocrine characteristics and treatment analysis of obese patients with polycystic ovary syndrome[J]. Smart Healthcare, 2019, 5(7): 44-46.
[18]	张笑梅, 朱燕波, 邬宁茜, 等. 基于不同指标诊断的肥胖与中医体质的相关性分析[J]. 中医杂志, 2015, 56(3): 212-215. ZHANG X M, ZHU Y B, WU N Q, et al. Correlation analysis between obesity and traditional Chinese medicine constitution based on different diagnostic indicators[J]. Journal of Traditional Chinese Medicine, 2015, 56(3): 212-215.
[19]	虞晓含, 朱燕波, 王琦, 等. 代谢综合征与中医体质类型及相关危险因素关系的Logistic回归分析[J]. 中华中医药杂志, 2015, 30(10): 3536-3539. YU X H, ZHU Y B, WANG Q, et al. Logistic regression analysis of the relationship between metabolic syndrome and traditional Chinese medicine constitution types and related risk factors[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2015, 30(10): 3536-3539.
[20]	梁雪, 王琦, 沈昆, 等. 痰湿体质人群易发代谢综合征相关危险因素的调查研究[J]. 中华中医药杂志, 2017, 32(4): 1500-1503. LIANG X, WANG Q, SHEN K, et al. Investigation and study on risk factors related to metabolic syndrome in people with phlegm dampness constitution[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2017, 32(4): 1500-1503.
[21]	ZHANG N, LI C, GUO Y, et al. Study on the intervention effect of Qi Gong Wan prescription on patients with phlegm-dampness syndrome of polycystic ovary syndrome based on intestinal flora[J]. Evidence-Based Complementary Altern Med, 2020. DOI: 10.1155/2020/6389034.
[22]	倪磊, 潘雨, 任嘉彦, 等. 痰湿体质相关疾病的分析研究[J]. 吉林中医药, 2020, 40(8): 1011-1013. NI L, PAN Y, REN J Y, et al. Analysis and research on diseases related to phlegm dampness constitution[J]. Jilin Journal of Chinese Medicine, 2020, 40(8): 1011-1013.
[23]	马欢, 孟凡艳, 张杰. 痰湿与肥胖探析[J]. 辽宁中医药大学学报, 2020, 22(6): 64-67. MA H, MENG F Y, ZHANG J. Analysis of phlegm dampness and obesity[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(6): 64-67.
[24]	张婷, 马丹. 多囊卵巢综合征患者肥胖与高胰岛素、高雄激素血症的关系[J]. 海南医学, 2019, 30(13): 1701-1703. ZHANG T, MA D. The relationship between obesity and hyperinsulinemia and hyperandrogenism in patients with polycystic ovary syndrome[J]. Hainan Medical Journal, 2019, 30(13): 1701-1703.
[25]	秦静波, 王济, 王琦. 多囊卵巢综合征中医体质类型及辨体论治思路[J]. 中医杂志, 2016, 57(18): 1553-1556. QIN J B, WANG J, WANG Q. Traditional Chinese medicine constitution types and treatment strategies for polycystic ovarian syndrome[J]. Journal of Traditional Chinese Medicine, 2016, 57(18): 1553-1556.
[26]	CHEN Y, FANG S Y. Potential genetic polymorphisms predicting polycystic ovary syndrome[J]. Endocr Connect, 2018, 7(5): 187-195.
[27]	CONCHA C F, SIR P T, REACABARREN S E, et al. Epigenetics of polycystic ovary syndrome[J]. Rev Med Chil, 2017, 145(7): 907-915.
[28]	RODRIGUEA PARIS V, WONG X Y D, SOLON-BIET S M, et al. The interplay between PCOS pathology and diet on gut microbiota in a mouse model[J]. Gut Microbes, 2022, 14(1): 2085961. DOI: 10.1080/19490976.2022.2085961.
[29]	DI RENZO G C, CONRY J A, BLAKE J, et al. International federation of gynecology and obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals[J]. Int J Gynaecol Obstet, 2015, 131(3): 219-225.
[30]	MERKIN S S, PHY J L, SITES C K, et al. Environmental determinants of polycystic ovary syndrome[J]. Fertil Steril, 2016, 106(1): 16-24.
[31]	王琦. 论中医体质研究的3个关键问题(上)[J]. 中医杂志, 2006(4): 250-252. WANG Q. Three key issues in the study of traditional Chinese medicine constitution (part 1)[J]. Journal of Traditional Chinese Medicine, 2006(4): 250-252.
[32]	CAI M C, JIN Y S, YU C Q, et al. A network pharmacology analysis of Cang Fu Dao Tan Formula for the treatment of obese polycystic ovary syndrome[J]. Digital Chinese Medicine, 2020, 3(3): 148-162.
[33]	单珂, 高慧. 苍附导痰汤治疗痰湿内阻证肥胖型多囊卵巢综合征的临床效果[J]. 中国医药导报, 2022, 19(29): 130-133, 143. SHAN K, GAO H. Clinical efficacy of Cangfu Daotan Tang in treating obese polycystic ovary syndrome with phlegm dampness internal obstruction syndrome[J]. China Medical Herald, 2022, 19(29): 130-133.
[34]	甘小利, 邓文华. 任督脉灸联合穴位埋线治疗肥胖型多囊卵巢综合征临床研究[J]. 中国中医药现代远程教育, 2022, 20(18): 98-101. GAN X L, DENG W H. Clinical study on the combination of Ren Du meridian moxibustion and acupoint thread embedding treatment for obese polycystic ovary syndrome[J]. Chinese Medicine Modern Distance Education of China, 2022, 20(18): 98-101.
[35]	李玉嫦, 冯婷, 何明静. 耳穴压豆法联合二甲双胍对肥胖型多囊卵巢综合征患者胰岛素抵抗的影响[J]. 中国医学创新, 2020, 17(25): 153-157. LI Y C, FENG T, HE M J. The effect of ear acupoint pressing method combined with metformin on insulin resistance in obese patients with polycystic ovary syndrome[J]. Medical Innovation of China, 2020, 17(25): 153-157.
[36]	王庆伟. 中药熏蒸疗法联合情志护理对肥胖型多囊卵巢综合征患者临床疗效的影响[J]. 西部中医药, 2022, 35(2): 129-132. WANG Q W. The effect of traditional Chinese medicine fumigation therapy combined with emotional care on the clinical efficacy of obese patients with polycystic ovary syndrome[J]. Western Journal of Traditional Chinese Medicine, 2022, 35(2): 129-132.
[37]	包丰源, 招辉. 中医情志疗法的理论创新与实践应用[J]. 江西中医药, 2022, 53(8): 17-20. BAO F Y, ZHAO H. Theoretical innovation and practical application of traditional chinese medicine emotional therapy[J]. Jiangxi Journal of Traditional Chinese Medicine, 2022, 53(8): 17-20.
[38]	万水云, 陈伟环, 单婉冰. 营养疗法结合二甲双胍对肥胖型多囊卵巢综合征伴胰岛素抵抗患者生殖激素指标及妊娠率的影响[J]. 中国医药指南, 2022, 20(25): 100-103. WAN S Y, CHEN W H, SHAN W B. The effect of nutritional therapy combined with metformin on reproductive hormone indicators and pregnancy rate in obese polycystic ovary syndrome patients with insulin resistance[J]. Guide of China Medicine, 2022, 20(25): 100-103.
[39]	张晓云, 索琦霞, 孙京. 肥胖型多囊卵巢综合征患者实施营养干预治疗对血脂、血糖及妊娠率的影响研究[J]. 中国性科学, 2020, 29(11): 67-70. ZHANG X Y, SUO Q X, SUN J. Study on the effects of nutritional intervention on blood lipids, blood glucose, and pregnancy rate in obese patients with polycystic ovary syndrome[J]. Chinese Journal of Human Sexuality, 2020, 29(11): 67-70.
[40]	吴慧娴, 徐燕. 营养及运动干预对肥胖型多囊卵巢综合征不孕患者的效果分析[J]. 系统医学, 2020, 5(22): 112-114. WU H X, XU Y. Effect analysis of nutritional and exercise interventions on infertile patients with obese polycystic ovary syndrome[J]. Systems Medicine, 2020, 5(22): 112-114.
[41]	SHELE G, GENKIL J, SPEELMAN D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome[J]. J Funct Morphol Kinesiol, 2020, 5(2): 35. DOI: 10.3390/jfmk5020035.